Related Experiment Video
Updated: Jun 4, 2026

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression
D S Markovic1, K Vinnakota, N van Rooijen
1Max Delbrück Center for Molecular Medicine, Cellular Neuroscience, Robert Rössle Str. 10, 13125 Berlin, Germany.
Abstract:
Glioma cells release soluble factors, which induce the expression of membrane type 1 matrix metalloprotease (MT1-MMP) in tumor associated microglia and then exploit MT1-MMP mediated matrix degradation for invasion. Here, we show that minocycline blocked the increase in MT1-MMP expression and activity in cultivated microglia stimulated with glioma conditioned medium. Glioma growth within an organotypic brain slice preparation was reduced by minocycline and this reduction depended on the presence of microglia. Glioma growth in an experimental mouse model was strongly reduced by the addition of minocycline to drinking water, compared to untreated controls. Coherently, we observed in our orthotopic glioma implantation model, that MT1-MMP was abundantly expressed in glioma associated microglia in controls, but was strongly attenuated in tumors of minocycline treated animals. Overall, our study indicates that the clinically approved antibiotic minocycline is a promising new candidate for adjuvant therapy against malignant gliomas.
Insights
The antibiotic minocycline reduces glioma growth by blocking microglia-mediated invasion. This suggests minocycline as a potential adjuvant therapy for malignant gliomas.
Area of Science:
- Neuro-oncology
- Immunology
- Molecular Biology
Background:
- Glioma cells promote tumor-associated microglia (TAM) to express membrane type 1 matrix metalloprotease (MT1-MMP).
- MT1-MMP facilitates glioma invasion through matrix degradation.
- Targeting this pathway presents a therapeutic opportunity.
Purpose of the Study:
- To investigate the effect of minocycline on MT1-MMP expression in microglia.
- To evaluate minocycline's efficacy in reducing glioma growth in vitro and in vivo.
- To determine the role of microglia in minocycline's anti-glioma effects.
Main Methods:
- Cultured microglia were stimulated with glioma conditioned medium.
- MT1-MMP expression and activity were assessed.
- Glioma growth was measured in organotypic brain slice and orthotopic mouse models.
- Minocycline was administered orally in drinking water.
Main Results:
- Minocycline inhibited MT1-MMP expression and activity in stimulated microglia.
- Minocycline significantly reduced glioma growth in brain slice preparations, dependent on microglia presence.
- Oral minocycline administration markedly reduced glioma growth in a mouse model.
- MT1-MMP expression in microglia within gliomas was significantly attenuated by minocycline treatment.
Conclusions:
- Minocycline effectively blocks MT1-MMP mediated glioma invasion.
- Minocycline demonstrates significant anti-glioma efficacy in preclinical models.
- Minocycline is a promising candidate for adjuvant therapy in malignant gliomas.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
